David Pernock Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Pernock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Pernock. David Pernock is a Chairman and CEO in Fibrocell Science, Inc. ($FCSC) and an Chief Executive Officer in Fibrocell Science, Inc. ($FCSC) and a Director in Fibrocell Science, Inc. ($FCSC) and a Director in EAGLE PHARMACEUTICALS, INC. ($EGRX) and a Pres & Chief Operating Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX) and a Pres. & Chief Comm. Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Address: C/O 405 EAGLEVIEW BOULEVARD EXTON 19341 PA
Companies in which David Pernock is an Insider
EAGLE PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Pernock: Pres & Chief Operating Officer, Pres. & Chief Comm. Officer, Director
Holdings: 54,625 shares
Current Value: $3,793,160
Latest Transaction: Feb 04 2021
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Fibrocell Science, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Pernock: Chairman and CEO, Chief Executive Officer, Director
Holdings: 105,600 shares
Current Value: $73,920
Latest Transaction: Dec 02 2016
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David Pernock
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2021 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres & Chief Operat ... | Grant | A | 0.00 | 9,700 | 0 | 54,625 | 44.9 K to 54.6 K (+21.59 %) |
| Jan 26 2021 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres & Chief Operat ... | Payment of Exercise | F | 47.70 | 1,892 | 90,248 | 44,925 | 46.8 K to 44.9 K (-4.04 %) |
| Jan 11 2021 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres & Chief Operat ... | Payment of Exercise | F | 50.97 | 906 | 46,179 | 46,817 | 47.7 K to 46.8 K (-1.90 %) |
| Jan 07 2021 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres & Chief Operat ... | Payment of Exercise | F | 50.02 | 2,088 | 104,442 | 47,723 | 49.8 K to 47.7 K (-4.19 %) |
| Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Payment of Exercise | F | 57.98 | 1,793 | 103,958 | 49,811 | 51.6 K to 49.8 K (-3.47 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 59.80 | 51,000 | 3,049,545 | 51,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Payment of Exercise | F | 57.38 | 904 | 51,872 | 51,604 | 52.5 K to 51.6 K (-1.72 %) |